Anhui Huaheng Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 741.56 million compared to CNY 579.98 million a year ago. Revenue was CNY 849.89 million compared to CNY 628.91 million a year ago.

Net income was CNY 191.24 million compared to CNY 128.99 million a year ago. Basic earnings per share from continuing operations was CNY 1.22 compared to CNY 0.82 a year ago. Diluted earnings per share from continuing operations was CNY 1.22 compared to CNY 0.82 a year ago.